RISS STAGE II PLASMA CELL MYELOMA
Clinical trials for RISS STAGE II PLASMA CELL MYELOMA explained in plain language.
Never miss a new study
Get alerted when new RISS STAGE II PLASMA CELL MYELOMA trials appear
Sign up with your email to follow new studies for RISS STAGE II PLASMA CELL MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could four drugs be better than three for myeloma?
Disease control Recruiting nowThis phase 3 trial compares a four-drug combination (daratumumab, bortezomib, lenalidomide, and dexamethasone) against a three-drug regimen (daratumumab, lenalidomide, and dexamethasone) in 1,450 people with newly diagnosed multiple myeloma who are not candidates for early stem c…
Matched conditions: RISS STAGE II PLASMA CELL MYELOMA
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
2000 volunteers help create a gold standard for cancer blood tests
Knowledge-focused Recruiting nowThis study collects blood and tissue samples from 2000 people—some with cancer and some without—to create a blinded reference set. Researchers will use these samples to evaluate how well new blood tests can detect many types of cancer early. The goal is to improve the accuracy of…
Matched conditions: RISS STAGE II PLASMA CELL MYELOMA
Sponsor: Alliance for Clinical Trials in Oncology • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC